A rare cause of drug-induced hepatitis in an immunocompromised patient and the role of glutathione

被引:0
|
作者
Viplove Senadhi
Deepika Arora
Manish Arora
Franklin Marsh
机构
[1] Division of Gastroenterology and Hepatology and Brater Scholar,Indiana Institute for Personalized Medicine,Indiana University School of Medicine,Indianapolis,IN 46202,United States
[2] Elmhurst Hospital/Mount Sinai School of Medicine,New York City,New York,NY 10005,United States
[3] Division of Gastroenterology and Hepatology,University of Maryland and National Institute of Health,Baltimore/Washington DC,MD 21742,United States
[4] Division of Gastroenterology and Hepatology,New York Hospital-Weill Cornell Medical Center,New York City,New York,NY 10005,United States
关键词
Glutathione; Human immunodeficiency virus; Acquired immune deficiency syndrome; Immuno-compromised; Drug induced hepatitis; Hepatotoxicity; N-acetylcysteine; Herbal Medications;
D O I
暂无
中图分类号
R575.1 [肝炎];
学科分类号
1002 ; 100201 ;
摘要
The Food and Drug Administration (FDA) has issued a warning on numerous herbal drugs, including many popular products at General Nutrition Centers (GNC), regarding unstudied hepatotoxicity. There have been recent reports of GNC products such as hydroxycut and herbalife, causing drug-induced hepatitis. Herbal medications are over-the-counter products and are not investigated thoroughly by the FDA. Given that the mostcommon outpatient laboratory abnormality is elevated liver transaminases, a sign of hepatocellular toxicity; it is not surprising that some of these products end up causing hepatic dysfunction, especially when taken in large volume. There are numerous herbal supplements that are hepatotoxic, however, these medications have a much more significant effect in human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome patients, which is secondary to depleted glutathione. We present a rare case of drug induced hepatitis secondary to herbal medications used to treat HIV and elucidate the role of glutathione depletion in immunocompromised patients.
引用
收藏
页码:248 / 251
页数:4
相关论文
共 50 条
  • [1] A rare cause of drug-induced hepatitis in an immunocompromised patient and the role of glutathione
    Senadhi, Viplove
    Arora, Deepika
    Arora, Manish
    Marsh, Franklin
    WORLD JOURNAL OF HEPATOLOGY, 2012, 4 (08) : 248 - 251
  • [2] DRUG-INDUCED HEPATITIS - A RARE COMPLICATION OF ORAL ANTICOAGULANTS
    HOHLER, T
    SCHNUTGEN, M
    HELMREICHBECKER, I
    MAYET, WJ
    ZUMBUSCHENFELDE, KHM
    JOURNAL OF HEPATOLOGY, 1994, 21 (03) : 447 - 449
  • [3] Drug-induced hepatitis
    Polunina, TE
    TERAPEVTICHESKII ARKHIV, 1999, 71 (12) : 46 - 49
  • [4] Drug-induced hepatitis, a rare complication of oral anticoagulant fluindione: a case report
    Sambarino, Audrey
    Pont, Emmanuelle
    Roux, Marielle
    Vial, Thierry
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 278 - 278
  • [5] Rhinosinus Mucormycosis with Drug-induced Pancytopenia in an Immunocompromised Severe COVID-19 Patient: A Success
    Mahajan, Anurag
    Tandon, Vineeta Singh
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 26 (03) : 394 - 397
  • [6] Metformin as a Rare Cause of Drug-Induced Liver Injury, a Case Report and Literature Review
    Zheng, Lin
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (01) : E315 - E317
  • [7] Dramatic increase in bilirubin after ERCP - Pethidine as a possible cause of drug-induced hepatitis
    Kluender, CN
    Klein, R
    Kohler, B
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2003, 41 (12): : 1157 - 1160
  • [8] Protective Effects of Exogenous Glutathione and Related Thiol Compounds against Drug-Induced Liver Injury
    Masubuchi, Yasuhiro
    Nakayama, Junpei
    Sadakata, Yuka
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (03) : 366 - 370
  • [9] Polypharmacy and the role of Primary Health Care: An interesting case of drug-induced hepatitis
    Tsimtsiou, Z.
    Kiparoglou, R.
    Asimakopoulos, A.
    Efthymiadou, E.
    Dantsi, F.
    ARCHIVES OF HELLENIC MEDICINE, 2012, 29 (06): : 731 - 733
  • [10] Acute hepatitis in a paediatric patient: immune-mediated drug-induced liver injury or albendazole-induced autoimmune hepatitis?
    Dragutinovic, Natasa
    Barac, Aleksandra
    Stevanovic, Goran
    Dordic, Irena
    Paglietti, Bianca
    Micic, Jelena
    Aleksic, Ema
    Stojnic, Jelena
    Nestorov, Jelena Martinov
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2022, 16 (10): : 1660 - 1663